North America is seeing a hiring boom in pharmaceutical industry AI roles
The proportion of pharmaceutical companies hiring for cloud related positions rose to a year-high in August 2021, with 42.7% of the companies included in our analysis recruiting for at least one such position.
North America extended its dominance for Artificial Intelligence (AI) hiring among pharmaceutical industry companies in the three months ending September.
The number of roles in North America made up 50.5% of total AI jobs – up from 46.3% in the same quarter last year.
That was followed by Asia-Pacific, which saw a 2.7 year-on-year percentage point change in AI roles.
The figures are compiled by GlobalData, which tracks the number of new job postings from key companies in various sectors over time. Using textual analysis, these job advertisements are then classified thematically.
GlobalData's thematic approach to sector activity seeks to group key company information by topic to see which companies are best placed to weather the disruptions coming to their industries.
These key themes, which include artificial intelligence, are chosen to cover "any issue that keeps a CEO awake at night".
Tracking them across job advertisements allows us to see which companies are leading the way on specific issues and which are dragging their heels – and importantly where the market is expanding and contracting.
Which countries are seeing the most growth for AI roles in pharmaceuticals?
The fastest growing country was the United States, which saw 46.3% of all AI job adverts in the three months ending June last year, increasing to 50.5% in the three months ending September this year.
That was followed by China (up 2.1 percentage points), Poland (up 1.9), and France (up 1.3).
The top country for AI roles in the pharmaceutical industry is the United States which saw 50.5% of all roles in the three months ending September.
Which cities are the biggest hubs for AI workers in pharmaceuticals?
Some 4.2% of all pharmaceutical industry AI roles were advertised in Cambridge (United States) in the three months ending September – more than any other city.
That was followed by Boston (United States) with 4.2%, Cambridge (United Kingdom) with 3.9 %, and South San Francisco (United States) with 2.6%.